Clinical trial · Observational
Locoregional Recurrence of Breast Cancer
Locoregional Recurrence After Radiotherapy in Breast Cancer Patients Based on Molecular Subtypes
NCT05988112CI-TRIAL-00078839unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
our study will be retrospective on breast cancer patients to detect relation between the locoregional recurrence of breast cancer after radiotherapy and the molecular subtypes
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Locoregional Recurrence | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Determine Local & regional recurrence according to different molecular subtypes.
- timeFrame
- within 5 years from diagnosis
- description
- radiologically or with re biopsy
- measure
- - 5-year free survival
- timeFrame
- within 5 years from diagnosis
- description
- radiologically
Secondary outcomes (1)
- measure
- Metastasis-Free Survival
- timeFrame
- within 5 years from diagnosis
- description
- radiologically
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 * Male or female * Histological proven breast cancer (IDC / ILC) * with known receptor status * Patient did mastectomy or breast conservative surgery +/- lymph node dissection . * received radiotherapy * on regular follow up Exclusion Criteria: * Metastatic from the start (stage 4)
References
Publications (0)
Data not yet available
No reference posted for this study.